The Priority Review

Regulation Brief

FDA determines BROMFED-DM syrup not withdrawn for safety or effectiveness

In a notice, the FDA said that BROMFED-DM (brompheniramine maleate, dextromethorphan hydrobromide, pseudoephedrine hydrochloride) syrup, 2 mg/5 mL; 10 mg/5 mL; 30 mg/5 mL, was not withdrawn from sale for reasons of safety or effectiveness. The AGENCY will continue to list the product in the Discontinued Drug Product List and may approve additional ANDAs that meet regulatory requirements.

Primary source

Federal Register notice, November 18, 2026

Determination That BROMFED-DM (Brompheniramine Maleate; Dextromethorphan Hydrobromide; Pseudoephedrine Hydrochloride) Syrup, 2 Milligrams/5 Milliliters; 10 Milligrams/5 Milliliters; 30 Milligrams/5 Milliliters, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

Read the source: Determination That BROMFED-DM (Brompheniramine Maleate; Dextromethorphan Hydrobromide; Pseudoephedrine Hydrochloride) Syrup, 2 Milligrams/5 Milliliters; 10 Milligrams/5 Milliliters; 30 Milligrams/5 Milliliters, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness federalregister.gov

Machine-summarized from the source above; not independently reported. How we use automation